• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

NQ301

CAS No. 130089-98-4

NQ301 ( NQ-301 | NQ 301 | NQ301 )

产品货号. M17241 CAS No. 130089-98-4

NQ301 是一种抗血栓剂,可抑制胶原蛋白挑战的兔血小板聚集(IC50:10 mg/mL)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥473 有现货
10MG ¥710 有现货
25MG ¥1163 有现货
50MG ¥1795 有现货
100MG ¥2592 有现货
500MG ¥5922 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥521 有现货

生物学信息

  • 产品名称
    NQ301
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    NQ301 是一种抗血栓剂,可抑制胶原蛋白挑战的兔血小板聚集(IC50:10 mg/mL)。
  • 产品描述
    NQ-301 is a Selective CD45 inhibitor with Antiplatelet and antithrombotic activities (IC50 = 200 nM). NQ301 inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. The antiplatelet activity of NQ301 may be mediated by inhibition of cytosolic Ca2+ mobilization, enhancement of cAMP production and inhibition of ATP secretion in activated platelets.
  • 体外实验
    NQ301 concentration-dependently inhibits collagen (10 mg/mL)-, U46619 (1 mg/mL)- and arachidonic acid (100 mg/mL)-challenged rabbit platelet aggregation, with IC50values of 0.60±0.02, 0.58±0.04 and 0.78±0.04 μM, respectively. NQ301 potently suppresses thromboxane B2 formation by platelets that are exposed to arachidonic acid in a concentration-dependent manner, but had no effect on the production of prostaglandin D2, indicating an inhibitory effect on thromboxane A2 synthase. NQ301 has a potential to inhibit thromboxane A2 synthase activity with thromboxane A2/prostaglandin H2 receptor blockade, and modulate arachidonic acid liberation as well as 12-hydroxy-5,8,10,14-eicosatetraenoic acid formation in platelets. NQ301 inhibits platelet aggregation by suppression of the intracellular pathway, rather than by direct inhibition of fibrinogen-GPIIb/IIIa complex binding. NQ301 significantly inhibits the increase of cytosolic Ca2+ concentration and ATP secretion, and also significantly increases platelet cAMP levels in the activated platelets. The antiplatelet activity of NQ301 may be mediated by inhibition of cytosolic Ca2+ mobilization, enhancement of cAMP production and inhibition of ATP secretion in activated platelets.
  • 体内实验
    ——
  • 同义词
    NQ-301 | NQ 301 | NQ301
  • 通路
    Angiogenesis
  • 靶点
    c-Met/HGFR
  • 受体
    arachidonic acid-challenged rabbit platelet aggregation| collagen-challenged rabbit platelet aggregation| U46619-challenged rabbit platelet aggregation
  • 研究领域
    Cardiovascular Disease|Infection
  • 适应症
    ——

化学信息

  • CAS Number
    130089-98-4
  • 分子量
    325.75
  • 分子式
    C18H12ClNO3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : ≥ 29 mg/mL. 89.03 mM
  • SMILES
    CC(=O)c1ccc(cc1)NC1=C(C(=O)c2ccccc2C1=O)Cl
  • 化学全称
    2-[(4-Acetylphenyl)amino]-3-chloro-1,4-naphthalenedione

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Jin YR, et al. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):162-7.
产品手册
关联产品
  • MGCD-265

    MGCD-265 是一种有效的、多靶点和 ATP 竞争性的 c-Met 和 VEGFR1/2/3 抑制剂,IC50 分别为 1 nM、3 nM/3 nM/4 nM。

  • JUN04542

    JUN04542 是一种 Axl Mer cMet KDR 抑制剂,用于治疗 Axl 和 Mer 受体酪氨酸激酶依赖性疾病。

  • MK-8033 hydrochlorid...

    MK-8033 是一种有效、特异性、双重 c-Met/Ron 激酶抑制剂,IC50 为 1/7 nM。